Nutromics logo

Nutromics

We exist to save millions of lives through continuous diagnostic monitoring

61 employees · est. 2017 · Melbourne, Australia

VS
Opticyte logo

Opticyte

Preventing Organ Failure Through Early Detection. Join our crowdfunding campaign today on StartEngine!

8 employees · est. 2016 · Seattle, United States

Opticyte is the older company (2017 vs 2016); Nutromics is the larger of the two.

Side-by-Side Comparison

Nutromics Opticyte
Founded
2017 2016 older
Headquarters
Melbourne, Australia Seattle, United States
Employees
61 larger 8
Industry
Biotechnology, Hardware, Health Care Medical Devices
Funding Stage
Series A Non Equity Assistance
Total Funding
$42.50M $5.70M
Funding Rounds
7 4
Services
Continuous Diagnostics, Real-Time Monitoring, Lab-on-a-Patch Development Not tracked yet
Target Customers
Healthcare Providers, Medical Professionals, Clinical Decision Makers Not tracked yet
Taxonomy
Continuous Diagnostic Monitoring, Lab-on-a-Patch, Wearable Health Technology, Molecular Insights, DNA-based Biosensors, Aptamers, Real-time Data, Antibiotic Monitoring, Sepsis Detection, Cardiology Insights, Triage Solutions, Therapeutic Drug Monitoring, Chronic Disease Management, Acute Disease Monitoring, AI-driven Healthcare Medical Device, Organ Failure Prevention, Sepsis, Continuous Monitoring, FDA Breakthrough Device Designation, Optical Spectroscopy, Multivariate Analysis, Clinical Data, Medical Device Commercialization, Cell O2 Monitor, Startup, Investment, Medical Technology, Healthcare Innovation, Seattle
Website
nutromics.com opticyte.com
Nutromics logo

About Nutromics

Nutromics, founded in 2017 and headquartered in Australia, is carving a niche in the intersection of Biotechnology, Health Care, and Medical Devices sectors. With its pioneering "lab-on-a-patch®" technology, Nutromics aims to transform diagnostic monitoring through a wearable device that provides co...

Opticyte logo

About Opticyte

Opticyte is a cutting-edge medical device startup based in the United States, founded in 2016. The company's slogan, "Preventing Organ Failure Through Early Detection," underlines its dedication to transforming the standard of care for organ failure, particularly in cases such as sepsis, where the c...

We will tell you when either one moves

BounceWatch watches Nutromics and Opticyte for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Nutromics and Opticyte — by email.

Frequently Asked Questions

Nutromics — We exist to save millions of lives through continuous diagnostic monitoring. Opticyte — Preventing Organ Failure Through Early Detection. Join our crowdfunding campaign today on StartEngine!. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Nutromics has raised $42.50M while Opticyte has raised $5.70M.
Nutromics and Opticyte operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Nutromics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Nutromics on 15 Mar 2026, and Opticyte on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy